Navigation Links
Boston Scientific Completes Enrollment in Benign Stricture Study of WallFlex® Biliary RX Stent
Date:10/18/2011

NATICK, Mass., Oct. 18, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has completed enrollment in a clinical trial to evaluate its WallFlex® Biliary RX Fully Covered Stent for the treatment of benign bile duct strictures (narrowing or blockages).  This multi-center, prospective study enrolled 187 patients at 13 centers in 11 countries worldwide.  Lead Investigators in the study are Professor Jacques Deviere, M.D., Ph.D., of Hospital Erasme in Brussels, and Professor Guido Costamagna, M.D., of Policlinico A. Gemelli in Rome.

The study includes patients with bile duct strictures associated with post liver transplant anastomosis (connection of two structures), prior abdominal surgery such as cholecystectomy (gall bladder removal) and chronic pancreatitis (inflammation of the pancreas).  The WallFlex Biliary RX Fully Covered Stent will remain in patients five to 11 months depending on the nature of the stricture.  The trial will evaluate the removal of the stents from patients as well as the effectiveness of temporary stenting for long-term benign biliary stricture resolution.  Patients will be followed for five years after stent removal.  

"This is a key milestone for this important trial," said Professor Deviere.  "We look forward to the findings, which will determine the potential benefits of this stent as a less-invasive alternative to surgery in these types of patients and as an endoscopic treatment option that may require fewer ERCP(1) procedures than plastic stenting."

The WallFlex Biliary RX Stent is constructed of braided, Platinol™ (platinum-cored Nitinol) wire and features three key attributes:  radial force to help maintain duct patency and resist migration, flexibility to aid in conforming to tortuous anatomies, and full-length radiopacity to enhance stent visibility under fluoroscopy.
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 2013  Decision Resources, one of the ... pharmaceutical and healthcare issues, finds that the ... efficacy endpoints, including overall survival and time ... over surveyed U.S. and European oncologists, prescribing ... breast cancer. The two novel emerging therapies ...
(Date:5/21/2013)... SANTA CLARA, Calif. , May 21, ... a game-changing embedded-ultrasound platform, today announced the ... Toolkit that allows complete network-based communications with ... demonstrate its latest embedded-ultrasound technology, including this ... Sao Paulo, Brazil ...
(Date:5/21/2013)... , May 21, 2013  The North Shore-LIJ ... used to measure hand-washing compliance at North Shore University ... introducing cameras in operating rooms at Forest ... http://photos.prnewswire.com/prnh/20130521/NY17810 ) The new pilot program strengthens ... their operating rooms (ORs), the first time in the ...
Breaking Medicine Technology:Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 2North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 3North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 4
... Dec. 8, 2010 Boehringer Ingelheim Pharmaceuticals, Inc. ... clinical trial in the United States to investigate ... 2992), for the treatment of patients with advanced ... administered irreversible inhibitor of both the epidermal growth ...
... Dec. 8, 2010 Sutro Biopharma, a biopharmaceutical ... with improved pharmaceutical properties, today announced that it ... officer (CSO). Dr. Hallam will lead Sutro,s ongoing ... protein biochemical synthesis platform for the research and ...
Cached Medicine Technology:Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib in Advanced Breast Cancer 2Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib in Advanced Breast Cancer 3Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib in Advanced Breast Cancer 4Sutro Biopharma Appoints Trevor Hallam, Ph.D., as Chief Scientific Officer 2
(Date:5/22/2013)... Those who have already gone through a ... that the hardest work is yet to come. As of ... band patients have special health needs that should be addressed ... Post Lap-Band Surgery” abclocal.go.com/kabc/story?section=news/food_coach&id=9078455). Bariatric surgeon Dr. Madan offers four ... that weight can be lost and kept off. , First, ...
(Date:5/22/2013)... 2013 Athletic-Minded Traveler LLC, a ... released today its 2013 U.S. Business Hotel “Fit ... the company’s recommendation after ongoing research of over ... by the editorial staff. Selection criteria included ... court, etc.), in-room workout choices, healthy food offerings, ...
(Date:5/21/2013)... May 22, 2013 The University of ... up with HEALTHY DINING to help Coloradans make healthier ... The new program is called HEALTHY DINING IN COLORADO. ... are already participating in Colorado. Restaurants will offer a ... adults emphasizing lean protein, vegetables, fruits, whole grains and ...
(Date:5/21/2013)... Swimsuit season is almost here. The "Get Ready ... begun with a 35% discount. , Cellulite forms mainly in ... the dreaded cellulite even if they are in shape. ... have been stored as toxic lymph and smashed together, giving ... specific program that works to dissolve the toxins and fatty ...
(Date:5/21/2013)... Texas (PRWEB) May 22, 2013 Feed ... increasing meat production industry value chain. Most of the ... form of injectable, pellets, liquids, and powders. There are ... different quantities and concentrations depending upon the type of ... minerals, and vitamins that provide essential nutrition to the ...
Breaking Medicine News(10 mins):Health News:The Lap Band Center: Dr. Atul Madan Offers Five Tips for Ongoing Weight Loss for Lap Band Patients 2Health News:The Lap Band Center: Dr. Atul Madan Offers Five Tips for Ongoing Weight Loss for Lap Band Patients 3Health News:2013: The 10 Healthiest Business Hotels in the U.S. 2Health News:Colorado Takes a Huge Step toward Transforming the Family Dining Experience 2Health News:Colorado Takes a Huge Step toward Transforming the Family Dining Experience 3Health News:Diminish Cellulite for Swimsuit Season; Sublime Beauty Introduces Cellulite Whisperer® Products in the "Get Ready for Summer Sale" 2Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 2Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 3Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 4
... from Cochrane Collaboration (International private organization which reports review ... from over 50 clinical trials involving influenza symptoms and ... the old drugs which were used against influenza were ... amantadine and rimantidine which were used to control symptoms ...
... Scotland are being encouraged to employ people with Asperger's ... with others. Scotland has a total of 50,000 people ... to them getting gainful employment. //People who suffer from ... interview. ,Even though the intelligence of ...
... from McMaster University has reported in the Journal Science ... that the scientists screened 480 strains of Streptomyces species ... the strains were multi-drug resistance //as they were tested ... ,The researchers were astonished by the ...
... transmission case is due today in Harbin court today. The ... blood collected from an infected couple who sold their blood ... Northeast China. // It was found that 15 people were ... and the other four got infection indirectly from the infected, ...
... Uttar Pradesh Government Railway Police and Junior doctors who ... by Meerut Nauchandi Express lead to injuring medicos and ... police personnel occupying the reserved seats of the medicos. ... state medical colleges for three days ordering enquiry and ...
... Adelaide Supreme Court jury is hearing the case of a HIV ... his accused of having unprotected sex with three of his girlfriend. ... not inform his girlfriends that he has the virus and has ... the three girls with whom he had unprotected sex is now ...
Cached Medicine News:
Use the Mo Bio Vortex adapter to process multiple samples at the same time. The adapter holds tubes horizontally to increase cell lysis and mixing efficiency. Ideal for bead beating procedures....
Use the Mo Bio Vortex adapter to process multiple samples at the same time. The adapter holds tubes horizontally to increase cell lysis and mixing efficiency. Ideal for bead beating procedures....
... Adapter in conjunction with the Vortex Genie 2 ... Mo Bio Vortex Adapter is an inexpensive alternative ... which offer the same technology. This particular ... one time and will fit any Vortex Genie ...
... V-500 with Vacuum Controller V-800 and water-cooled secondary ... Compact Housing Model V-500 ... to handle most vacuum applications. Applications ... two rotary evaporators Laboratory vacuum source ...
Medicine Products: